Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03376880 · ClinicalTrials.gov registry record

Respiratory Effects of Obesity in Children

A clinical trial, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
123
Enrollment target

NCT03376880: Completed study, sponsored by University of Texas Southwestern Medical Center.

NCT03376880 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03376880 has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
123 participants
Enrollment target

Study Summary

In obese children, excess fat on the thorax exerts an unfavorable burden on the respiratory system, particularly during exercise; however, it is unclear if this burden reduces exercise tolerance, provokes dyspnea on exertion, or contributes to respiratory symptoms that could be misdiagnosed as asthma, placing obese children at risk of unnecessary treatment and potentially a reluctance to exercise explaining reports of low physical activity and fitness levels, which are counterproductive to weight loss. The investigators will examine the respiratory effects of obesity in prepubescent boys and girls, including those with respiratory symptoms misdiagnosed as asthma, before and after 1) a program of weight loss and regular exercise and 2) continued weight gain as compared with prepubescent normal weight boys and girls before and after 1 year. These results will have broad and immediate clinical impact on the care of obese children, especially those with respiratory symptoms misdiagnosed as asthma, and the results could alter interventional approaches for preventing and treating childhood obesity.

Primary Outcome

Pulmonary function is comprised of several physiological variables but this study will primarily measure Lung Volume: FRC (liters) and TLC (liters)

Interventions

  • OTHER 1 year follow-up testing

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2017-04-26
Est. Completion 2024-07-31

What the finished NCT03376880 record still lists

NCT03376880 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which 1 year follow-up testing is the first listed.

NCT03376880 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03376880 about?

NCT03376880 is a clinical study titled "Respiratory Effects of Obesity in Children". In obese children, excess fat on the thorax exerts an unfavorable burden on the respiratory system, particularly during exercise; however, it is unclear if this burden reduces exercise tolerance, provokes dyspnea on exertion, or contributes to respiratory symptoms that could be misdiagnosed as asthm...

What is the current status of trial NCT03376880?

This trial is currently completed. The enrollment target is 123 participants. The study started on 2017-04-26. Estimated completion is 2024-07-31.

What interventions are being tested in trial NCT03376880?

The interventions under investigation include: 1 year follow-up testing (OTHER).

Who is sponsoring clinical trial NCT03376880?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05285891 · 123 participants · Phase 4

    Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

  • NCT05334368 · 123 participants · Phase 3

    Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

  • NCT06088355 · 123 participants · NA

    Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

  • NCT06111131 · 123 participants · NA

    Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03376880, the US trial registry maintained by the National Library of Medicine. NCT03376880 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.